Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.6K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.5K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

398
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
398

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nasopharyngeal Hairy Polyp Causing Pediatric Sleep-Disordered Breathing.

Ear, nose, & throat journal·2026
Same author

Letter Regarding "Effect of Race, Ethnicity, and Language on Adenotonsillectomy Outcomes in Pediatric Otolaryngology".

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2025
Same author

Chronic Facial Pain in an Adolescent.

JAMA otolaryngology-- head & neck surgery·2024
Same author

Middle Ear Fibrosis Contributes to Hearing Loss in Patients With Myhre Syndrome.

Ear, nose, & throat journal·2024
Same author

Myringosclerosis Mimicking Tympanic Membrane Cholesteatoma.

Ear, nose, & throat journal·2024
Same author

Oxymetazoline vs ofloxacin vs ciprofloxacin/dexamethasone- effects of drops on tympanostomy tube postoperative otorrhea.

American journal of otolaryngology·2022

Related Experiment Video

Updated: Apr 23, 2026

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

24.2K

Avoiding narcotic analgesics in young children.

Jeffrey D Carron

    Journal of the Mississippi State Medical Association
    |September 26, 2014
    PubMed
    Summary

    Recent FDA warnings on codeine use in children are shifting postoperative pain management. This trend favors over-the-counter pain medications for pediatric patients.

    Area of Science:

    • Pediatric Anesthesiology
    • Pharmacovigilance
    • Pain Management

    Background:

    • Concerns regarding codeine's safety profile in pediatric populations.
    • The U.S. Food and Drug Administration (FDA) has issued recent warnings.
    • Implications for established postoperative pain management strategies.

    Purpose of the Study:

    • To summarize recent FDA warnings concerning codeine in young children.
    • To outline the current trends in pediatric postoperative pain management.
    • To discuss the shift towards over-the-counter (OTC) analgesics.

    Main Methods:

    • Review of FDA safety communications and warnings.
    • Analysis of current clinical practice guidelines for pediatric pain control.
    • Literature review on the efficacy and safety of OTC pain relievers in children.

    More Related Videos

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
    07:23

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

    Published on: July 29, 2014

    34.7K
    Investigating Pain-Related Avoidance Behavior using a Robotic Arm-Reaching Paradigm
    09:00

    Investigating Pain-Related Avoidance Behavior using a Robotic Arm-Reaching Paradigm

    Published on: October 3, 2020

    3.5K

    Related Experiment Videos

    Last Updated: Apr 23, 2026

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
    12:20

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

    Published on: June 10, 2013

    24.2K
    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
    07:23

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

    Published on: July 29, 2014

    34.7K
    Investigating Pain-Related Avoidance Behavior using a Robotic Arm-Reaching Paradigm
    09:00

    Investigating Pain-Related Avoidance Behavior using a Robotic Arm-Reaching Paradigm

    Published on: October 3, 2020

    3.5K

    Main Results:

    • FDA warnings highlight potential risks associated with codeine in pediatric patients.
    • A noticeable shift in prescribing patterns towards non-opioid analgesics.
    • Increased utilization of over-the-counter medications for postoperative pain relief in children.

    Conclusions:

    • The FDA warnings necessitate a re-evaluation of codeine use in pediatric postoperative care.
    • Current pain management protocols are adapting to prioritize safer alternatives.
    • Over-the-counter pain medicines represent a growing component of pediatric pain management strategies.